J&J, Medtronic back CereVasc’s $85M funding round

J&J, Medtronic back CereVasc’s $85M funding round is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Nick Paul Taylor · 2026-06-05

CereVasc is developing a minimally invasive treatment for the buildup of fluid in the brain.

Source: MedTech Dive